Commodore Capital reported a 9.9% stake in Karyopharm Therapeutics KPTI · 1,950,000 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.9%
Last report: First report
Shares held: 1,950,000 sh
Class: Common Stock, $0.0001 par value
Stock: Karyopharm Therapeutics KPTI
Holder: Commodore Capital
Event date: 26/03/26
Filed: 26/04/02

First 5%+ report · 9.9% stake

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 02/24~04/25

Commodore Capital's other 5% stake reports

Commodore Capital
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
Commodore Capital
5% stakeInflaRx
5% stake
InflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
Commodore Capital
5% stakePalisade Bio
5% stake
Palisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeJatt II Acquisition
5% stake
Jatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeRelay Therapeutics
5% stake
Relay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14